Jonathan Young, Chief Operating Officer at Akero Therapeutics, Inc. (AKRO), sold 9,200 shares at $24.33 ($224K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($224k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.33 | 4,600 | $112K | 50.0% |
| 2 | $24.33 | 4,600 | $112K | 50.0% |
| Total | $24.33 avg | 9,200 | $224K | 100% |
| Filing → |
| AKRO | SELL | 2025-09-04 | $705K | — | Filing → |
| AKRO | SELL | 2025-08-13 | $1.2M | — | Filing → |
| AKRO | SELL | 2025-06-20 | $159K | — | Filing → |